Literature DB >> 22134943

Nitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infections.

Burke A Cunha, Paul E Schoch, Jean R Hage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22134943      PMCID： PMC3228625          DOI： 10.4065/mcp.2011.0411

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  7 in total

1.  The renal transport of nitrofurantoin. Effect of acid-base balance upon its excretion.

Authors:  M W WOODRUFF; R L MALVIN; I M THOMPSON
Journal:  JAMA       Date:  1961-04-01       Impact factor: 56.272

Review 2.  New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited.

Authors:  Burke A Cunha
Journal:  Med Clin North Am       Date:  2006-11       Impact factor: 5.456

3.  Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis.

Authors:  James A McKinnell; Nicholas S Stollenwerk; Chin W Jung; Loren G Miller
Journal:  Mayo Clin Proc       Date:  2011-05-16       Impact factor: 7.616

4.  Pharmacokinetic considerations in the treatment of urinary tract infections.

Authors:  B A Cunha; J B Comer
Journal:  Conn Med       Date:  1979-06

5.  Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens.

Authors:  C C McOsker; P M Fitzpatrick
Journal:  J Antimicrob Chemother       Date:  1994-05       Impact factor: 5.790

6.  Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1998-09       Impact factor: 5.790

Review 7.  Nitrofurantoin--current concepts.

Authors:  B A Cunha
Journal:  Urology       Date:  1988-07       Impact factor: 2.649
  7 in total
  10 in total

1.  Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.

Authors:  Sandra J Aedo; Juechun Tang; Mark P Brynildsen
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Comparative Evaluation of Fosfomycin Activity with other Antimicrobial Agents against E.coli Isolates from Urinary Tract Infections.

Authors:  Ahmed Sardar; Sreekanth Reddy Basireddy; Anwar Navaz; Manisha Singh; Vasanti Kabra
Journal:  J Clin Diagn Res       Date:  2017-02-01

3.  Isolation and Characterization of Lytic Proteus Virus 309.

Authors:  Joshua Aaron; Leonardo J van Zyl; Leon M T Dicks
Journal:  Viruses       Date:  2022-06-15       Impact factor: 5.818

4.  Intervention to improve the quality of antimicrobial prescribing for urinary tract infection: a cluster randomized trial.

Authors:  Akke Vellinga; Sandra Galvin; Sinead Duane; Aoife Callan; Kathleen Bennett; Martin Cormican; Christine Domegan; Andrew W Murphy
Journal:  CMAJ       Date:  2015-11-16       Impact factor: 8.262

Review 5.  A new strategy to fight antimicrobial resistance: the revival of old antibiotics.

Authors:  Nadim Cassir; Jean-Marc Rolain; Philippe Brouqui
Journal:  Front Microbiol       Date:  2014-10-20       Impact factor: 5.640

6.  Genomic insights into nitrofurantoin resistance mechanisms and epidemiology in clinical Enterobacteriaceae.

Authors:  John Osei Sekyere
Journal:  Future Sci OA       Date:  2018-02-27

Review 7.  Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines.

Authors:  Dorota Olender; Justyna Żwawiak; Lucjusz Zaprutko
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-29

8.  In-Vitro Biofilm Formation and Antimicrobial Resistance of Escherichia coli in Diabetic and Nondiabetic Patients.

Authors:  Sunayana Raya; Ankit Belbase; Laxmi Dhakal; Krishna Govinda Prajapati; Reena Baidya; Nabin Kishor Bimali
Journal:  Biomed Res Int       Date:  2019-09-19       Impact factor: 3.411

9.  US-Focused Conceptual Health Care Decision-Analytic Models Examining the Value of Pivmecillinam Relative to Current Standard-of-Care Agents Among Adult Patients With Uncomplicated Urinary Tract Infections due to Enterobacterales.

Authors:  Thomas P Lodise; Anne Santerre Henriksen; Thomas Hadley; Nimish Patel
Journal:  Open Forum Infect Dis       Date:  2021-10-15       Impact factor: 3.835

10.  Epidemiology of Complicated Urinary Tract Infections due to Enterobacterales Among Adult Patients Presenting in Emergency Departments Across the United States.

Authors:  Thomas P Lodise; Teena Chopra; Brian H Nathanson; Katherine Sulham; Mauricio Rodriguez
Journal:  Open Forum Infect Dis       Date:  2022-06-24       Impact factor: 4.423
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.